Thermo Fisher details plans for $2.2B common-stock sale

Thermo Fisher ($TMO) has released details concerning the execution of a $2.2 billion sale of common stock--a massive undertaking designed to help cover its $13.6 billion bid to buy Life Technologies ($LIFE). As Mass High Tech/Boston Business Journal reports, plans call for offering 29.6 million shares in something known as "forward sale agreements" with banks, so the transaction will delay dilution of stock. Of course, if underwriters exercise all over-allotments, the total offering could reach as high as $2.5 billion, the company noted in a regulatory filing cited in the story. Story | SEC filing

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.